1700630210
1700630211
[11] Elsharkawy AM, Mann DA. Nuclear fector-κB and the hepatic inflammation-fibrosis-cancer axis. Hepatology, 2007, 46(2)
:590-597.
1700630212
1700630213
[12] Bergamini C, Sgarra C, Trerotoli P, et al. Laminin-5 stimulates hepatic cellular carcinoma growth through a different of 26β4 and 23β1 integrins. Hepatology, 2007, 46(6)
:1801-1809.
1700630214
1700630215
[13] Li Z, Dranoff JA, Chan EP. Transforming growth factor-β and substorate stiffness regulate portal fibroblast activation in cultur. Ibid, 2007, 46(4)
:1246-1256.
1700630216
1700630217
[14] Zeisberg M, Yang C, Martino M, et al. Fibroblast derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem, 2007, 287
:23337-23347.
1700630218
1700630219
[15] Gorrell MD. Liver fibrosis: The hepatocytes revisited. Hepatology, 2007, 46(5)1659-1661.
1700630220
1700630221
[16] Weng HL, Wang BE, Jia JD, et al. Effect of IFN-γ on hepatic fibrosis in chronic hepatitis B virus infection: A randomized controlled study. Chin Gastroenterol Hepatol, 2005, 3(8)
:819-828.
1700630222
1700630223
[17] Weng HL, Mertens PR, Gresnner AM, et al. IFN-γ abrograters profibrogenic TGFβ signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatology, 2007, 46(1)
:295-303.
1700630224
1700630225
[18] Weng HL, Ciuclan L, Liu Y, et al. Profibrogenic TGF-β/activin preceptor-like kinase 5 signaling via CTGF expression in hepatocytes. Hepatology, 2007, 46(4)
:1257-1270.
1700630226
1700630227
[19] Guha IN, Parkes J, Roderick P, et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simpler markers. Hepatology, 2008, 47(2)
:455-460.
1700630228
1700630229
[20] Fontana RJ, Goodman ZD, Dienstage JL, et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis. Hepatology, 2008, 47(3)
:789-789.
1700630230
1700630231
[21] Lai KKY, Kolippakkam D, Beretta L. Comprehensive and quantitative proteome profiling of the mouse liver and plasma. Heptology, 2008, 47(3)
:1043-1051.
1700630232
1700630233
[22] Morra R, Munteanu M, Bedossa P, et al. Diagnostic value of serum protein profiliny by SELD1-TOF protein-chip compared with a biochemipal marker, fibro test for the diagnosis of advenced fibrosis in patents with chronic hepatitis C. Aliment Pharmacol Ther, 2007, 15; 26(6)
:847-858.
1700630234
1700630235
[23] Wasmuth HE, Trartwein C. CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosis. Hepatology, 2007, 45(2)
:543-545.
1700630236
1700630237
[24] Weiskirchen R, Meurer SK. Bone morphogenetic protein-7 in focus: A member of the TGFβ superfamily is implicated in the maintenance of liver health. Hepatology, 2007, 45(5)
:1324-1325.
1700630238
1700630239
[25] Kinoshita K, Limuro Y, Otogawa K, et al. Aenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut, 2007, 56(5)
:706-714.
1700630240
1700630241
[26] Zou C, Ma J, Wang X, et al. Lack of fas antagonism by met in human fatty liver disease. Nat Med, 2007, 13(9)
:1078-1085.
1700630242
1700630243
[27] Roderfeld M, Weiskirchen R, Waq-ner S, et al. Inhibition of hepatic fibrogensis by MMP-9 mutants in mice. Fase B J, 2006, 20(3)
:444-454.
1700630244
1700630245
[28] Hu YB, Li DG, Lu HM, et al. Modified synthetic SiRN A targeting TIMP-2 Ihibits hepatic fibrogensis in rats. J Gene Med, 2007, 9(3)
:217-229.
1700630246
1700630247
[29] Wang CH, Lee TH, Lu CN, et al. Electroporative alpha-MSH gene transfer attenuate thioacetamide induced murine hepatic fibrosis by MMP and TIMP modulation. J Gene Ther, 2006, 13(13)
:1000-1009.
1700630248
1700630249
[30] Prockros P, Jeffers L, Afdhal N, et al. Final results of A double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-rlb in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology, 2007, 45(1)
:569-578.
1700630250
1700630251
[31] 蔡卫民．γ干扰素抗肝纤维化研究的体会．传染病信息，2008，待发表.
1700630252
1700630253
[32] 翁红雷，蔡卫民．IFN-γ与肝纤维化治疗．中华肝脏病杂志，2008，待发表.
1700630254
1700630255
（蔡卫民）
1700630256
1700630257
1700630258
1700630259
[
上一页 ]
[ :1.70063021e+09 ]
[
下一页 ]